Biosimilars Global Congress 2014 Europe within One Week
Biosimilars Global Congress 2014 Europe is going to be held in Sep 17th to Sep 19th 2014 from 8:30 am to 6:00 pm in Financial District, Boston.
This Congress is to give a platform for interactive discussion and communication about practical strategies on challenges, innovations, technologies and concepts regarding biosimilars. Chief executives, executive directors, heads and team leaders working within biologics, biotechnology, biogenerics, biopharmaceuticals, R & D, clinical immunology, pharmacovigilance…will attend this congress.
Topics will focus on global regulatory perspective, current regulations and future challenges for development of biosimilars in Europe & US, impact of healthcare system on biosimilars, patients perspective on biosimilars, manufacturing & development process considerations of biosimilars, CMC requirements for biosimilars product development/manufacturing, to name a few.
The market for biosimilars is expected to reach $ 1.9 billion to $ 2.6 billion by the end of 2015 and is expected to be a large part of world market for global pharmaceutical.
For years, we have been the pioneer and undisputed global leader in the emerging market for biosimilars. Using our proprietary gene screening and amplification system, we have developed a series of biosimilars stable cell lines which have been accepted by CMO’s and manufacturers worldwide to produce cGMP material.
Contact us now for more information about our similar cell line data base.
Article link: Biosimilars Global Congress 2014 Europe within One WeekTags: biosimilars, biotechnology, biologics, biosimilars stable cell line